Search results for: 'btk inhibitor 1'
-
A8394 CHIR-124Target: FLT3|GSK-3|Chk|PDGFRSummary: Chk1 inhibitor,novel and potent
-
A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: Dual inhibitor of tyrosine and phosphoinositide kinases
-
A2024 PD168393Target: PDGFR|FGFR|EGFR|PKC|insulinSummary: EGFR inhibitor
-
A3022 Pazopanib (GW-786034)Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
B7354 SU 16fTarget: PDGFRSummary: PDGFRβ inhibitor
-
A3750 Regorafenib hydrochlorideTarget: Raf|VEGFR|PDGFR|c-Kit|c-RETSummary: Tyrosine kinase inhibitor
-
B5954 Dasatinib MonohydrateTarget: PDGFR|c-Kit|Bcr-Abl|SrcSummary: Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).